Glioneuronal and Neuronal Tumors in Adults: World Health Organization 2021 Imaging and Molecular Updates.
2/5 보강
TL;DR
This review aims to highlight the key updated features of glioneuronal and neuronal tumors in adults based on the fifth edition of the WHO Classification of Central Nervous System Tumors by clinical and epidemiological presentation, imaging appearance, and pathology.
OpenAlex 토픽 ·
Glioma Diagnosis and Treatment
Epilepsy research and treatment
Neurogenesis and neuroplasticity mechanisms
This review aims to highlight the key updated features of glioneuronal and neuronal tumors in adults based on the fifth edition of the WHO Classification of Central Nervous System Tumors by clinical a
APA
Melissa B. Warstadt, Tyler Richards, et al. (2026). Glioneuronal and Neuronal Tumors in Adults: World Health Organization 2021 Imaging and Molecular Updates.. AJNR. American journal of neuroradiology, 47(4), 867-878. https://doi.org/10.3174/ajnr.A9102
MLA
Melissa B. Warstadt, et al.. "Glioneuronal and Neuronal Tumors in Adults: World Health Organization 2021 Imaging and Molecular Updates.." AJNR. American journal of neuroradiology, vol. 47, no. 4, 2026, pp. 867-878.
PMID
41238398 ↗
Abstract 한글 요약
Glioneuronal and neuronal tumors are defined histologically by the presence of mixed glial and neuronal elements in the case of glioneuronal tumors, and by neuronal elements in the case of neuronal tumors. In 2021, the World Health Organization (WHO) published the latest edition of a CNS tumor classification and added 3 new glioneuronal tumors, as well as further delineated histologic, immunohistochemical, and molecular markers associated with the diagnosis of these tumors. This review aims to highlight the key updated features of glioneuronal and neuronal tumors in adults based on the fifth edition of the WHO Classification of Central Nervous System Tumors by clinical and epidemiological presentation, imaging appearance, and pathology.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.